Skip to main content
Premium Trial:

Request an Annual Quote

NIH Now Says NIDDK Genomics Lab Not Yet Ready to Offer Microarray Services to All Institutes

NEW YORK (GenomeWeb News) — Correcting a statement it made last week, the Genomics Core Laboratory of the National Institute of Diabetes, Digestive and Kidney Diseases today said it has not begun providing its microarray services to all NIH institutes.
Last week, Genomics Core Director Margaret Cam said the extension is open-ended, unless the NIH decides to use other providers, and reflects greater fiscal responsiveness to budget demands within the NIH.  
In fact, the NIDDK “has been working on appropriate mechanisms for providing services but has not completed the process to date,” a second NIH official told GenomeWeb News today.
The message, sent by e-mail from a spokesperson for the NIH’s Office of the Scientific Director for the NIDDK Division of Intramural Research, added: “I believe that they are working on a mechanism for providing services, to others, but all the details haven't been worked out yet.”
The NIDDK Genomics Core currently uses Affymetrix and Codelink array platforms, and will offer its services to other NIH researchers for $400 per sample or $350 per sample for orders over 100 samples.
The service includes sample QC; automated target labeling; hybridization; preliminary statistical data analysis; storage and management of microarray data; online access to raw and processed data and GEO submission reports.
The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.